Raymond James Doubles Cogent Price Target to $60 After Landmark GIST Trial Data
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameCogent Biosciences Inc (formerly Unum Therapeutics Inc)
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









